MORN Morningstar, Inc.
Investment Advice · Nasdaq · SEC CIK 1289419 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY18.5%
TTM EPS YoY29.7%
Revenue 3-yr CAGR9.9%
Net income 3-yr CAGR84.5%
Margins
Gross margin—
Operating margin24.5%
Net margin17.0%
FCF margin18.8%
EBITDA margin32.4%
Returns
ROE35.1%
ROA11.9%
ROIC (approx.)23.4%
Asset turnover0.70x
Leverage & solvency
Liabilities / assets74.0%
Debt / equity1.65x
Current ratio1.05x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.44x
Accruals ratio-5.2%
Payout ratio17.2%
Capex / revenue5.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 | FY2023*2023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.45B | $2.28B | $2.04B | $1.87B | $1.70B |
| Cost of revenue | $952.90M | $895.70M | $843.50M | $779.30M | $698.40M |
| SG&A expense | $334.00M | $327.20M | $355.80M | $400.40M | $318.40M |
| Operating income | $526.60M | $484.80M | $230.60M | $167.80M | $257.00M |
| Pretax income | $495.70M | $473.90M | $174.10M | $130.60M | $250.50M |
| Income tax | $121.50M | $104.00M | $33.00M | $56.50M | $62.60M |
| Net income | $374.20M | $369.90M | $141.10M | $70.50M | $193.30M |
| EBITDA | $716.50M | $675.20M | $415.50M | $334.40M | $407.70M |
| EPS (basic) | 8.93 | 8.64 | 3.31 | 1.65 | 4.50 |
| EPS (diluted) | 8.87 | 8.58 | 3.29 | 1.64 | 4.45 |
| Dividends declared per share | 1.87 | 1.67 | 1.53 | 1.46 | 1.31 |
| Weighted avg. shares (diluted) | 42.20M | 43.10M | 42.90M | 42.90M | 43.40M |
| Balance sheet | |||||
| Cash & equivalents | $474.50M | $502.70M | $337.90M | $376.60M | $483.80M |
| Short-term investments | $54.20M | $48.30M | $51.10M | $38.00M | $62.30M |
| Receivables | $390.40M | $358.10M | $343.90M | $307.90M | $268.90M |
| Current assets | $1.04B | $1.01B | $815.70M | $810.80M | $887.60M |
| PP&E, net | $231.90M | $218.90M | $207.70M | $199.40M | $171.80M |
| Goodwill | $1.61B | $1.56B | $1.58B | $1.57B | $1.21B |
| Intangibles | $379.30M | $408.80M | $484.40M | $548.60M | $328.20M |
| Total assets | $3.59B | $3.55B | $3.40B | $3.47B | $2.86B |
| Current liabilities | $1.05B | $967.30M | $880.80M | $882.50M | $783.50M |
| Short-term debt | $0 | $0 | $32.10M | $32.10M | $0 |
| Long-term debt | $1.07B | $698.60M | $972.40M | $1.11B | $359.40M |
| Total debt | $1.07B | $698.60M | $1.00B | $1.14B | $359.40M |
| Total liabilities | $2.37B | $1.93B | $2.08B | $2.27B | $1.45B |
| Shareholders' equity | $1.22B | $1.62B | $1.33B | $1.21B | $1.42B |
| Net debt | $598.10M | $195.90M | $666.60M | $765.10M | -$124.40M |
| Shares outstanding | 39.74M | 42.87M | 42.73M | 42.48M | 43.14M |
| Cash flow statement | |||||
| Operating cash flow | $589.70M | $591.60M | $316.40M | $297.80M | $449.90M |
| Capital expenditure | $147.10M | $142.70M | $119.10M | $129.50M | $101.80M |
| Free cash flow | $442.60M | $448.90M | $197.30M | $168.30M | $348.10M |
| Investing cash flow | -$139.30M | -$21.30M | -$81.90M | -$799.30M | -$167.70M |
| Financing cash flow | -$514.70M | -$384.40M | -$278.40M | $415.10M | -$211.80M |
| Depreciation & amortization | $189.90M | $190.40M | $184.90M | $166.60M | $150.70M |
| Stock-based compensation | $56.40M | $54.70M | $52.80M | $83.20M | $41.90M |
| Dividends paid | $76.90M | $69.30M | $63.90M | $61.50M | $54.20M |
| Share buybacks | $787.00M | $11.60M | $1.40M | $226.00M | $1.30M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.